Interestingly, a recent study demonstrated that combination of anti-BAFF and anti-CD20 reduced B cells, liver portal infiltration and bile duct lesion in the ARE-Del mouse model of PBC (27). This evidence concerns the gene TNFSF13B and primary biliary cholangitis.